Pharmaceutical News

April 14, 2011 - Quintiles will contribute $2.6 million over four years to support I-SPY 2, a unique adaptive clinical trial designed to develop breast cancer therapies twice as quickly and at one-fifth the cost of current methods.

March 28, 2011 – Quintiles announced that its online social community at www.MediGuard.org has reached 2.5 million members in just three years.

March 25, 2011 – Quintiles has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).

March 22, 2011 - As a result of recent unfavorable global credit market conditions, Quintiles Transnational Corp. (“Quintiles”) it has postponed its previously announced plans to enter into new $2.425 billion credit facilities.

March 13, 2011 – Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products, while emerging Asian companies seek new capabilities to globalize products.

March 10, 2011 - Quintiles Transnational Holdings Inc. announced that it has commenced a cash tender offer for any and all of the Company’s outstanding $525.0 million aggregate principal amount 9.50% senior notes due 2014.

March 8, 2011 – Quintiles is pursuing plans to enter into new $2.425 billion credit facilities.

February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.

February 23, 2011 – Quintiles lab is one of only of a limited number of central labs in the U.S. to meet the rigorous requirements for medical laboratory quality and competence established by the International Organization for Standardization (ISO).

February 11, 2011 - For the third year in a row, Quintiles has been recognized as one of the top organizations in the world for workforce training and development excellence with its inclusion in the Training “Top 125.”